Michael R. Olin
Affiliations: | Neuroscience | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Oncology, Neuroscience Biology, ImmunologyGoogle:
"Michael Olin"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Webb MJ, Kottke T, Kendall BL, et al. (2023) Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses. Molecular Therapy Oncolytics. 29: 129-142 |
Alghamri MS, Banerjee K, Mujeeb AA, et al. (2022) Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy. Acs Nano |
Ogino H, Taylor JW, Nejo T, et al. (2021) Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T-cell response in low-grade gliomas. The Journal of Clinical Investigation |
Alghamri MS, McClellan BL, Hartlage MS, et al. (2021) Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments. Frontiers in Pharmacology. 12: 680021 |
Ampudia-Mesias E, Puerta-Martinez F, Bridges M, et al. (2021) CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
Xiong Z, Ampudia Mesias E, Pluhar GE, et al. (2019) CD200 Checkpoint Reversal:A Novel Approach to Immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Olin MR, Ampudia-Mesias E, Pennell CA, et al. (2019) Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma. Cancers. 11 |
Moertel C, Pluhar GE, Ampudia-Mesias E, et al. (2019) IMMU-23. TARGETING THE CD200 CHECKPOINT TO ENHANCE IMMUNOTHERAPY FOR CNS TUMORS Neuro-Oncology. 21: ii97-ii98 |
Olin M, Ampudia-Mesias E, Pennell CA, et al. (2018) CADD-14. TARGETING THE CD200 CHECKPOINT FOR THE FIGHT AGAINST CENTRAL NERVOUS SYSTEM TUMORS Neuro-Oncology. 20: vi278-vi279 |
Pluhar E, Ampudia-Mesias E, Xiong Z, et al. (2018) Immu-03. Targeting The Cd200 Checkpoint Blockade For The Fight Against Central Nervous System Tumors Neuro-Oncology. 20 |